Kenneth E Mah1, Jeffrey A Alten2, Timothy T Cornell3, David T Selewski4, David Askenazi5, Julie C Fitzgerald6, Alexis Topjian6, Kent Page7, Richard Holubkov7, Beth S Slomine8, James R Christensen8, J Michael Dean7, Frank W Moler9. 1. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; The Heart Institute, Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. Electronic address: Kenneth.Mah@cchmc.org. 2. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; The Heart Institute, Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. 3. Department of Pediatrics, Lucile Packard Children's Hospital Stanford, Stanford University, Palo Alto, CA, United States. 4. Department of Pediatrics, Medical University of South Carolina, Charleston, SC, United States. 5. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, United States. 6. Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States. 7. Department of Pediatrics, University of Utah, Salt Lake City, UT, United States. 8. Kennedy Krieger Institute and Johns Hopkins University, Baltimore, MD, United States. 9. Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, United States.
Abstract
AIM: Determine 1) frequency and risk factors for acute kidney injury (AKI) after in-hospital cardiac arrest (IHCA) in the Therapeutic Hypothermia after Pediatric Cardiac Arrest In-Hospital (THAPCA-IH) trial and associated outcomes; 2) impact of temperature management on post-IHCA AKI. METHODS: Secondary analysis of THAPCA-IH; a randomized controlled multi-national trial at 37 children's hospitals. ELIGIBILITY: Serum creatinine (Cr) within 24 h of randomization. OUTCOMES: Prevalence of severe AKI defined by Stage 2 or 3 Kidney Disease Improving Global Outcomes Cr criteria. 12-month survival with favorable neurobehavioral outcome. Analyses stratified by entire cohort and cardiac subgroup. Risk factors and outcomes compared among cohorts with and without severe AKI. RESULTS: Subject randomization: 159 to hypothermia, 154 to normothermia. Overall, 80% (249) developed AKI (any stage), and 66% (207) developed severe AKI. Cardiac patients (204, 65%) were more likely to develop severe AKI (72% vs 56%,p = 0.006). Preexisting cardiac or renal conditions, baseline lactate, vasoactive support, and systolic blood pressure were associated with severe AKI. Comparing hypothermia versus normothermia, there were no differences in severe AKI rate (63% vs 70%,p = 0.23), peak Cr, time to peak Cr, or freedom from mortality or severe AKI (p = 0.14). Severe AKI was associated with decreased hospital survival (48% vs 65%,p = 0.006) and decreased 12-month survival with favorable neurobehavioral outcome (30% vs 53%,p < 0.001). CONCLUSION: Severe post-IHCA AKI occurred frequently especially in those with preexisting cardiac or renal conditions and peri-arrest hemodynamic instability. Severe AKI was associated with decreased survival with favorable neurobehavioral outcome. Hypothermia did not decrease incidence of severe AKI post-IHCA.
AIM: Determine 1) frequency and risk factors for acute kidney injury (AKI) after in-hospital cardiac arrest (IHCA) in the Therapeutic Hypothermia after Pediatric Cardiac Arrest In-Hospital (THAPCA-IH) trial and associated outcomes; 2) impact of temperature management on post-IHCA AKI. METHODS: Secondary analysis of THAPCA-IH; a randomized controlled multi-national trial at 37 children's hospitals. ELIGIBILITY: Serum creatinine (Cr) within 24 h of randomization. OUTCOMES: Prevalence of severe AKI defined by Stage 2 or 3 Kidney Disease Improving Global Outcomes Cr criteria. 12-month survival with favorable neurobehavioral outcome. Analyses stratified by entire cohort and cardiac subgroup. Risk factors and outcomes compared among cohorts with and without severe AKI. RESULTS: Subject randomization: 159 to hypothermia, 154 to normothermia. Overall, 80% (249) developed AKI (any stage), and 66% (207) developed severe AKI. Cardiac patients (204, 65%) were more likely to develop severe AKI (72% vs 56%,p = 0.006). Preexisting cardiac or renal conditions, baseline lactate, vasoactive support, and systolic blood pressure were associated with severe AKI. Comparing hypothermia versus normothermia, there were no differences in severe AKI rate (63% vs 70%,p = 0.23), peak Cr, time to peak Cr, or freedom from mortality or severe AKI (p = 0.14). Severe AKI was associated with decreased hospital survival (48% vs 65%,p = 0.006) and decreased 12-month survival with favorable neurobehavioral outcome (30% vs 53%,p < 0.001). CONCLUSION: Severe post-IHCA AKI occurred frequently especially in those with preexisting cardiac or renal conditions and peri-arrest hemodynamic instability. Severe AKI was associated with decreased survival with favorable neurobehavioral outcome. Hypothermia did not decrease incidence of severe AKI post-IHCA.
Authors: Tara M Neumayr; Jeff Gill; Julie C Fitzgerald; Avihu Z Gazit; Jose A Pineda; Robert A Berg; J Michael Dean; Frank W Moler; Allan Doctor Journal: Pediatr Crit Care Med Date: 2017-10 Impact factor: 3.624
Authors: Manchang Liu; Yideng Liang; Srinivasulu Chigurupati; Justin D Lathia; Mikhail Pletnikov; Zhaoli Sun; Michael Crow; Christopher A Ross; Mark P Mattson; Hamid Rabb Journal: J Am Soc Nephrol Date: 2008-04-02 Impact factor: 10.121
Authors: Ericka L Fink; Robert S B Clark; Patrick M Kochanek; Michael J Bell; R Scott Watson Journal: Pediatr Crit Care Med Date: 2010-01 Impact factor: 3.624
Authors: Frank W Moler; Faye S Silverstein; Richard Holubkov; Beth S Slomine; James R Christensen; Vinay M Nadkarni; Kathleen L Meert; Brittan Browning; Victoria L Pemberton; Kent Page; Marianne R Gildea; Barnaby R Scholefield; Seetha Shankaran; Jamie S Hutchison; John T Berger; George Ofori-Amanfo; Christopher J L Newth; Alexis Topjian; Kimberly S Bennett; Joshua D Koch; Nga Pham; Nikhil K Chanani; Jose A Pineda; Rick Harrison; Heidi J Dalton; Jeffrey Alten; Charles L Schleien; Denise M Goodman; Jerry J Zimmerman; Utpal S Bhalala; Adam J Schwarz; Melissa B Porter; Samir Shah; Ericka L Fink; Patrick McQuillen; Theodore Wu; Sophie Skellett; Neal J Thomas; Jeffrey E Nowak; Paul B Baines; John Pappachan; Mudit Mathur; Eric Lloyd; Elise W van der Jagt; Emily L Dobyns; Michael T Meyer; Ronald C Sanders; Amy E Clark; J Michael Dean Journal: N Engl J Med Date: 2017-01-24 Impact factor: 91.245
Authors: Robert A Berg; Vinay M Nadkarni; Amy E Clark; Frank Moler; Kathleen Meert; Rick E Harrison; Christopher J L Newth; Robert M Sutton; David L Wessel; John T Berger; Joseph Carcillo; Heidi Dalton; Sabrina Heidemann; Thomas P Shanley; Athena F Zuppa; Allan Doctor; Robert F Tamburro; Tammara L Jenkins; J Michael Dean; Richard Holubkov; Murray M Pollack Journal: Crit Care Med Date: 2016-04 Impact factor: 7.598
Authors: Frank W Moler; Faye S Silverstein; Richard Holubkov; Beth S Slomine; James R Christensen; Vinay M Nadkarni; Kathleen L Meert; Amy E Clark; Brittan Browning; Victoria L Pemberton; Kent Page; Seetha Shankaran; Jamie S Hutchison; Christopher J L Newth; Kimberly S Bennett; John T Berger; Alexis Topjian; Jose A Pineda; Joshua D Koch; Charles L Schleien; Heidi J Dalton; George Ofori-Amanfo; Denise M Goodman; Ericka L Fink; Patrick McQuillen; Jerry J Zimmerman; Neal J Thomas; Elise W van der Jagt; Melissa B Porter; Michael T Meyer; Rick Harrison; Nga Pham; Adam J Schwarz; Jeffrey E Nowak; Jeffrey Alten; Derek S Wheeler; Utpal S Bhalala; Karen Lidsky; Eric Lloyd; Mudit Mathur; Samir Shah; Theodore Wu; Andreas A Theodorou; Ronald C Sanders; J Michael Dean Journal: N Engl J Med Date: 2015-04-25 Impact factor: 91.245